GU Cancers 2022 | Importance and challenges of biomarker research for kidney cancer

Hyung Kim, MD, Cedars-Sinai Medical Center, Los Angeles, CA, discusses the challenges of developing biomarkers for kidney cancer and emphasizes their importance in determining the best treatment path for patients. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.